Societal CDMO(REPH)
2.09 0.00 0.0%
| 今开：0.0 | 昨收：2.09 |
| 最高：0.0 | 最低：0.0 |
| 涨停价：0.0 | 跌停价：0.0 |
| 总市值：1.17926555E8 |
Societal CDMO的最新讨论
牛唐2019-03-18 17:34
$Recro制药(REPH)$ 的N1539治疗术后疼痛在去年吃了CRL，主要原因是数据及次要终点的选择不符合FDA的预期，这个月24号第二次申请，过的概率有，但不会很大查看全文
![[加]](http://js.xueqiu.com/ugc/images/face/emoji_52_plus.png?v=1 "[加]"){kind=small}
![[哭泣]](http://js.xueqiu.com/ugc/images/face/emoji_09_cry.png?v=1 "[哭泣]"){kind=small}
Societal CDMO的公告
$Recro Pharma(REPH)$ CORRESP [Cover] - Correspondence Filed: 2016-12-12 AccNo: 0001193125-16-790927 Size: 7 KB 网页链接
$Recro Pharma(REPH)$ 8-K - Current report Filed: 2017-01-06 AccNo: 0001193125-17-004571 Size: 14 MBItem 8.01: Other EventsItem 9.01: Financial Statements and Exhibits 网页链接
$Recro Pharma(REPH)$ SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals Filed: 2016-12-19 AccNo: 0000935836-16-001230 Size: 50 KB 网页链接
$Recro Pharma(REPH)$ 内部交易: 2016-12-15,Director,ALTOMARI ALFRED ,买入,1500普通股, $6.55
$Recro Pharma(REPH)$ SC 13G - Statement of acquisition of beneficial ownership by individuals Filed: 2016-12-16 AccNo: 0001193805-16-004383 Size: 527 KB 网页链接
$Recro Pharma(REPH)$ 8-K - Current report Filed: 2016-12-16 AccNo: 0001193125-16-795790 Size: 13 KBItem 8.01: Other Events 网页链接
$Recro Pharma(REPH)$ EFFECT - Notice of Effectiveness Filed: 2016-12-13 AccNo: 9999999995-16-006441 Size: 1 KB 网页链接
$Recro Pharma(REPH)$ 424B4 - Prospectus [Rule 424(b)(4)] Filed: 2016-12-14 AccNo: 0001193125-16-792160 Size: 1 MB 网页链接
$Recro Pharma(REPH)$ SC 13D/A [Amend] - General statement of acquisition of beneficial ownership Filed: 2016-12-14 AccNo: 0000919574-16-017149 Size: 90 KB 网页链接
$Recro Pharma(REPH)$ S-1/A [Amend] - General form for registration of securities under the Securities Act of 1933 Filed: 2016-12-13 AccNo: 0001193125-16-790920 Size: 1 MB 网页链接